If you're in Indian pharma, Novo Nordisk's warning is a stark signal

If you're in Indian pharma, Novo Nordisk's warning is a stark signal. Global price pressure isn't just a US issue; it's a looming reality for all markets, including India's export-driven industry.

The era of easy margins is ending. Companies must pivot from volume to value-based innovation and cost efficiency to stay competitive. This pressure will redefine market entry strategies.

https://pharma.economictimes.indiatimes.com/news/financial-performance/wegovy-maker-novo-nordisk-warns-unprecedented-price-pressure-to-hit-sales/127912126